A phase-I study evaluating the combination of pegylated liposomal doxorubicin and paclitaxel as salvage chemotherapy in metastatic breast cancer previously treated with anthracycline

Phase I ◽

Phase I Study ◽

Liposomal Doxorubicin ◽

Metastatic Breast ◽

Salvage Chemotherapy ◽

Abstract CT234: A phase I study of MM-302, a HER2-targeted PEGylated liposomal doxorubicin, in patients with HER2+ metastatic breast cancer

10.1158/1538-7445.am2015-ct234 ◽

2015 ◽

Cited By ~ 15

Author(s):

Patricia LoRusso ◽

Ian Krop ◽

Kathy Miller ◽

Cynthia Ma ◽

Barry A. Siegel ◽

...

Keyword(s):

Breast Cancer ◽

Phase I ◽

Phase I Study ◽

Liposomal Doxorubicin ◽

Metastatic Breast ◽

Pegylated Liposomal Doxorubicin

Phase I study of pegylated liposomal doxorubicin (CA) and docetaxel (T) bimonthly in the first-line treatment of metastatic breast cancer (MBC): The CAT regimen

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.818 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 818-818

Author(s):

J.-P. Guastalla ◽

A.-C. Hardy-Bessard ◽

J.-F. Geay ◽

H. Cure ◽

I. Ray-Coquard ◽

...

Keyword(s):

Breast Cancer ◽

Phase I ◽

Phase I Study ◽

Liposomal Doxorubicin ◽

Metastatic Breast ◽

Line Treatment ◽

First Line ◽

First Line Treatment

Phase I study of pegylated liposomal doxorubicin (CA) and docetaxel (T) bimonthly in the first-line treatment of metastatic breast cancer (MBC): The CAT regimen

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.818 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 818-818

Author(s):

J.-P. Guastalla ◽

A.-C. Hardy-Bessard ◽

J.-F. Geay ◽

H. Cure ◽

I. Ray-Coquard ◽

...

Keyword(s):

Breast Cancer ◽

Phase I ◽

Phase I Study ◽

Liposomal Doxorubicin ◽

Metastatic Breast ◽

Line Treatment ◽

First Line ◽

First Line Treatment

A phase I study of vinflunine in combination with capecitabine in patients with metastatic breast cancer previously treated with anthracyclines and taxanes

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-011-1767-9 ◽

2011 ◽

Vol 69 (4) ◽

pp. 871-879 ◽

Cited By ~ 10

Author(s):

M. Campone ◽

N. Isambert ◽

E. Bourbouloux ◽

H. Roché ◽

J. Bonneterre ◽

...

Keyword(s):

Breast Cancer ◽

Phase I ◽

Phase I Study ◽

Metastatic Breast ◽

Phase I-II Study of Pegylated Liposomal Doxorubicin Combined With Weekly Paclitaxel as First-Line Treatment in Patients With Metastatic Breast Cancer

American Journal of Clinical Oncology ◽

10.1097/01.coc.0000217552.69036.16 ◽

2006 ◽

Vol 29 (3) ◽

pp. 267-275 ◽

Cited By ~ 9

Author(s):

Hugues Bourgeois ◽

Aur??lie Ferru ◽

Alain Lortholary ◽

Thierry Delozier ◽

Mich??le Boisdron-Celle ◽

...

Keyword(s):

Breast Cancer ◽

Phase I ◽

Liposomal Doxorubicin ◽

Metastatic Breast ◽

Weekly Paclitaxel ◽

Line Treatment ◽

First Line ◽

First Line Treatment

Myotax: A phase II trial of docetaxel plus non-pegylated liposomal doxorubicin as first-line therapy of metastatic breast cancer previously treated with adjuvant anthracyclines

European Journal of Cancer ◽

10.1016/j.ejca.2011.08.004 ◽

2011 ◽

Vol 47 (16) ◽

pp. 2396-2402 ◽

Cited By ~ 8

Author(s):

E. Curtit ◽

P. Nouyrigat ◽

N. Dohollou ◽

E. Levy ◽

A. Lortholary ◽

...

Keyword(s):

Breast Cancer ◽

Liposomal Doxorubicin ◽

Phase Ii Trial ◽

Metastatic Breast ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

A Phase I Study of an All-Oral Combination of Vinorelbine/Capecitabine in Patients with Metastatic Breast Cancer Previously Treated with Anthracyclines and/or Taxanes

Clinical Breast Cancer ◽

10.3816/cbc.2006.n.057 ◽

2006 ◽

Vol 7 (5) ◽

pp. 401-405 ◽

Cited By ~ 14

Author(s):

Pirkko-Liisa Kellokumpu-Lehtinen ◽

Kaisa Sunela ◽

Ilari Lehtinen ◽

Heikki Joensuu ◽

Johanna Sjöström-Mattson

Keyword(s):

Breast Cancer ◽

Phase I ◽

Phase I Study ◽

Metastatic Breast ◽

Cardiac Safety with High Cumulative Dose of Pegylated Liposomal Doxorubicin in Patients with Metastatic Breast Cancer Previously Treated with Conventional Anthracyclines

Advances in Breast Cancer Research ◽

10.4236/abcr.2020.93005 ◽

2020 ◽

Vol 09 (03) ◽

pp. 55-65

Author(s):

Ahmed Refaat ◽

Dalia O. Mohamed ◽

Elsayed Mostafa Ali ◽

Salah Mabrouk Khallaf

Keyword(s):

Breast Cancer ◽

Cumulative Dose ◽

Liposomal Doxorubicin ◽

Metastatic Breast ◽

Cardiac Safety ◽

High Cumulative Dose ◽

Pegylated liposomal doxorubicin (Lipo-Dox®) combined with cyclophosphamide and 5-fluorouracil is effective and safe as salvage chemotherapy in taxane-treated metastatic breast cancer: an open-label, multi-center, non-comparative phase II study

BMC Cancer ◽

10.1186/s12885-015-1433-4 ◽

2015 ◽

Vol 15 (1) ◽

Cited By ~ 15

Author(s):

Kun-Ming Rau ◽

Yung-Chang Lin ◽

Yen-Yang Chen ◽

Jen-Shi Chen ◽

Kuan-Der Lee ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Study ◽

Metastatic Breast ◽

Salvage Chemotherapy ◽

Open Label

Pegylated liposomal doxorubicin (PLD) plus cyclophosphamide as 1st-line therapy for metastatic breast cancer in patients previously treated with anthracyclines

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.745 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 745-745 ◽

Cited By ~ 1

Author(s):

M. E. Trudeau ◽

L. Provencher ◽

L. Panasci ◽

L. Yelle ◽

J. Latreille ◽

...

Keyword(s):

Breast Cancer ◽

Liposomal Doxorubicin ◽

Metastatic Breast ◽

Line Therapy ◽